The landscape of non-cystic fibrosis bronchiectasis (NCFB) treatment is undergoing a significant transformation with the emergence of Brinsupri (brensocatib), a…
Read More
Cavidi AB’s BOLD Technology Sets New Standards in Immunoassay Sensitivity and Precision for Biomedical Research and Diagnostics
Cavidi AB is making significant strides in enhancing the capabilities of immunoassays, a cornerstone technique in diagnostics and biomedical research,…
Read More
